AIkido Pharma Inc. (AIKI): Price and Financial Metrics
AIkido Pharma Inc. (AIKI)
Today's Latest Price: $1.22 USD
Updated Jan 25 6:55pm
Add AIKI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
AIKI Stock Summary
- The ratio of debt to operating expenses for AIkido Pharma Inc is higher than it is for about just 0.5% of US stocks.
- With a price/sales ratio of 4,733.63, AIkido Pharma Inc has a higher such ratio than 99.68% of stocks in our set.
- Over the past twelve months, AIKI has reported earnings growth of -3,478.61%, putting it ahead of merely 0.62% of US stocks in our set.
- Stocks that are quantitatively similar to AIKI, based on their financial statements, market capitalization, and price volatility, are AQB, ATOM, LYL, VTVT, and SPCE.
- AIKI's SEC filings can be seen here. And to visit AIkido Pharma Inc's official web site, go to aikidopharma.com.
AIKI Stock Price Chart Interactive Chart >
AIKI Price/Volume Stats
| Current price | $1.22 | 52-week high | $5.52 |
| Prev. close | $1.24 | 52-week low | $0.47 |
| Day low | $1.18 | Volume | 6,251,400 |
| Day high | $1.30 | Avg. volume | 20,389,414 |
| 50-day MA | $0.76 | Dividend yield | N/A |
| 200-day MA | $0.75 | Market Cap | 42.60M |
AIkido Pharma Inc. (AIKI) Company Bio
Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.
Loading social stream, please wait...